| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.88e-07 | 54 | 24 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.38e-06 | 2 | 24 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.38e-06 | 2 | 24 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.00e-06 | 21 | 24 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.15e-06 | 3 | 24 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.21e-05 | 140 | 24 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 6.06e-05 | 64 | 24 | 3 | GO:0140296 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.32e-04 | 83 | 24 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.44e-04 | 15 | 24 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.46e-04 | 86 | 24 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.91e-04 | 739 | 24 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.12e-04 | 753 | 24 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.73e-04 | 562 | 24 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 8.04e-04 | 35 | 24 | 2 | GO:0051019 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 8.99e-04 | 37 | 24 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.02e-03 | 167 | 24 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.43e-03 | 417 | 24 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.70e-03 | 51 | 24 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.98e-03 | 55 | 24 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.35e-03 | 60 | 24 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.52e-03 | 229 | 24 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | p53 binding | 3.83e-03 | 77 | 24 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.93e-03 | 78 | 24 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 4.54e-03 | 84 | 24 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 4.77e-03 | 582 | 24 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.53e-03 | 303 | 24 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6.46e-03 | 1459 | 24 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 6.63e-03 | 102 | 24 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 6.88e-03 | 104 | 24 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.11e-02 | 1160 | 24 | 5 | GO:0030674 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.29e-02 | 775 | 24 | 4 | GO:0016746 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.47e-02 | 1244 | 24 | 5 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.60e-02 | 1271 | 24 | 5 | GO:0000987 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.05e-02 | 891 | 24 | 4 | GO:0008270 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.06e-02 | 1356 | 24 | 5 | GO:0060090 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.10e-02 | 187 | 24 | 2 | GO:0016922 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NFATC1 IFI16 YEATS2 CREBBP NFIB PHC3 EP300 ZNF318 PCGF2 MED1 | 1.62e-06 | 1399 | 24 | 10 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NFATC1 IFI16 YEATS2 CREBBP NFIB PHC3 EP300 ZNF318 PCGF2 MED1 | 1.78e-06 | 1413 | 24 | 10 | GO:1902679 |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 7.77e-06 | 4 | 24 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 8.84e-06 | 35 | 24 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 8.84e-06 | 35 | 24 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 1.11e-05 | 262 | 24 | 5 | GO:0031669 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.59e-05 | 1053 | 24 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | cell quiescence | 3.62e-05 | 8 | 24 | 2 | GO:0044838 | |
| GeneOntologyBiologicalProcess | regulation of binding | 8.00e-05 | 396 | 24 | 5 | GO:0051098 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.54e-04 | 16 | 24 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.54e-04 | 16 | 24 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | cellular response to hepatocyte growth factor stimulus | 2.19e-04 | 19 | 24 | 2 | GO:0035729 | |
| GeneOntologyBiologicalProcess | response to hepatocyte growth factor | 2.69e-04 | 21 | 24 | 2 | GO:0035728 | |
| GeneOntologyBiologicalProcess | regulation of tubulin deacetylation | 2.96e-04 | 22 | 24 | 2 | GO:0090043 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.14e-04 | 115 | 24 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 3.23e-04 | 23 | 24 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 3.23e-04 | 23 | 24 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 3.23e-04 | 23 | 24 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | tubulin deacetylation | 3.53e-04 | 24 | 24 | 2 | GO:0090042 | |
| GeneOntologyBiologicalProcess | megakaryocyte development | 4.15e-04 | 26 | 24 | 2 | GO:0035855 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | 4.22e-04 | 566 | 24 | 5 | GO:0031667 | |
| GeneOntologyBiologicalProcess | cell cycle phase | 4.47e-04 | 27 | 24 | 2 | GO:0022403 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 4.81e-04 | 28 | 24 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 5.17e-04 | 29 | 24 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte proliferation | 5.17e-04 | 29 | 24 | 2 | GO:0010839 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 5.68e-04 | 336 | 24 | 4 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 6.14e-04 | 343 | 24 | 4 | GO:0071559 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell proliferation | 6.30e-04 | 32 | 24 | 2 | GO:2000647 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 7.12e-04 | 34 | 24 | 2 | GO:0090311 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 7.12e-04 | 34 | 24 | 2 | GO:2000629 | |
| GeneOntologyBiologicalProcess | monocyte differentiation | 7.54e-04 | 35 | 24 | 2 | GO:0030224 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 7.77e-04 | 1390 | 24 | 7 | GO:0045944 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 8.07e-04 | 999 | 24 | 6 | GO:0071824 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 8.89e-04 | 38 | 24 | 2 | GO:0061384 | |
| GeneOntologyBiologicalProcess | positive regulation of binding | 9.80e-04 | 170 | 24 | 3 | GO:0051099 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 1.03e-03 | 41 | 24 | 2 | GO:0060325 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | 1.30e-03 | 420 | 24 | 4 | GO:0045089 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 1.36e-03 | 47 | 24 | 2 | GO:0006476 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA binding | 1.36e-03 | 47 | 24 | 2 | GO:0043392 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.39e-03 | 192 | 24 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 1.42e-03 | 48 | 24 | 2 | GO:0060323 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.42e-03 | 741 | 24 | 5 | GO:0006338 | |
| GeneOntologyBiologicalProcess | cellular response to radiation | 1.43e-03 | 194 | 24 | 3 | GO:0071478 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.45e-03 | 195 | 24 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.48e-03 | 49 | 24 | 2 | GO:0042771 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | 1.69e-03 | 451 | 24 | 4 | GO:0002833 | |
| GeneOntologyBiologicalProcess | biological phase | 1.72e-03 | 53 | 24 | 2 | GO:0044848 | |
| GeneOntologyBiologicalProcess | protein destabilization | 1.92e-03 | 56 | 24 | 2 | GO:0031648 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 1.92e-03 | 56 | 24 | 2 | GO:0010837 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 1.99e-03 | 57 | 24 | 2 | GO:0061383 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.03e-03 | 1194 | 24 | 6 | GO:0000902 | |
| GeneOntologyBiologicalProcess | protein deacylation | 2.06e-03 | 58 | 24 | 2 | GO:0035601 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 2.22e-03 | 226 | 24 | 3 | GO:0050680 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 2.43e-03 | 63 | 24 | 2 | GO:0098732 | |
| GeneOntologyBiologicalProcess | face development | 2.43e-03 | 63 | 24 | 2 | GO:0060324 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 2.50e-03 | 64 | 24 | 2 | GO:0010171 | |
| GeneOntologyBiologicalProcess | response to radiation | 2.52e-03 | 503 | 24 | 4 | GO:0009314 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 2.60e-03 | 850 | 24 | 5 | GO:0071363 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 2.63e-03 | 509 | 24 | 4 | GO:0044772 | |
| GeneOntologyCellularComponent | chromatin | 1.63e-04 | 1480 | 24 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.66e-04 | 94 | 24 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | PRC1 complex | 2.13e-04 | 19 | 24 | 2 | GO:0035102 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.24e-04 | 104 | 24 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.58e-04 | 109 | 24 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.58e-04 | 109 | 24 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | transferase complex | 6.20e-04 | 963 | 24 | 6 | GO:1990234 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 6.51e-04 | 972 | 24 | 6 | GO:0140535 | |
| GeneOntologyCellularComponent | nuclear ubiquitin ligase complex | 1.44e-03 | 49 | 24 | 2 | GO:0000152 | |
| GeneOntologyCellularComponent | PcG protein complex | 1.62e-03 | 52 | 24 | 2 | GO:0031519 | |
| GeneOntologyCellularComponent | nuclear body | 3.19e-03 | 903 | 24 | 5 | GO:0016604 | |
| GeneOntologyCellularComponent | transcription regulator complex | 4.41e-03 | 596 | 24 | 4 | GO:0005667 | |
| GeneOntologyCellularComponent | inclusion body | 4.76e-03 | 90 | 24 | 2 | GO:0016234 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 7.37e-03 | 352 | 24 | 3 | GO:0000151 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.62e-06 | 2 | 7 | 2 | HP:0034227 | |
| HumanPheno | Plantar crease between first and second toes | 1.62e-06 | 2 | 7 | 2 | HP:0008107 | |
| HumanPheno | High axial triradius | 1.62e-06 | 2 | 7 | 2 | HP:0001042 | |
| HumanPheno | Humoral immunodeficiency | 4.85e-06 | 3 | 7 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 4.85e-06 | 3 | 7 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 4.85e-06 | 3 | 7 | 2 | HP:0005895 | |
| HumanPheno | Laryngeal cartilage malformation | 4.85e-06 | 3 | 7 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 4.85e-06 | 3 | 7 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 4.85e-06 | 3 | 7 | 2 | HP:0000756 | |
| HumanPheno | Trichiasis | 9.70e-06 | 4 | 7 | 2 | HP:0001128 | |
| HumanPheno | Widened distal phalanges | 9.70e-06 | 4 | 7 | 2 | HP:0006200 | |
| HumanPheno | Visceral hemangioma | 9.70e-06 | 4 | 7 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 9.70e-06 | 4 | 7 | 2 | HP:0011087 | |
| HumanPheno | Vascular ring | 9.70e-06 | 4 | 7 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 9.70e-06 | 4 | 7 | 2 | HP:0031207 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.62e-05 | 5 | 7 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.62e-05 | 5 | 7 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.62e-05 | 5 | 7 | 2 | HP:0030421 | |
| HumanPheno | Large foramen magnum | 2.42e-05 | 6 | 7 | 2 | HP:0002700 | |
| HumanPheno | Deviated nasal septum | 3.39e-05 | 7 | 7 | 2 | HP:0004411 | |
| HumanPheno | Narrow nasal bridge | 3.62e-05 | 53 | 7 | 3 | HP:0000446 | |
| HumanPheno | Pilomatrixoma | 5.80e-05 | 9 | 7 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 5.80e-05 | 9 | 7 | 2 | HP:0002341 | |
| HumanPheno | Frontal hirsutism | 7.25e-05 | 10 | 7 | 2 | HP:0011335 | |
| HumanPheno | Abnormal subclavian artery morphology | 8.85e-05 | 11 | 7 | 2 | HP:0031251 | |
| HumanPheno | Overlapping toe | 9.10e-05 | 72 | 7 | 3 | HP:0001845 | |
| HumanPheno | Obstructive sleep apnea | 1.20e-04 | 79 | 7 | 3 | HP:0002870 | |
| HumanPheno | Facial grimacing | 1.25e-04 | 13 | 7 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 1.25e-04 | 13 | 7 | 2 | HP:0010562 | |
| HumanPheno | Parietal foramina | 1.46e-04 | 14 | 7 | 2 | HP:0002697 | |
| HumanPheno | Duplication of phalanx of hallux | 1.46e-04 | 14 | 7 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 1.46e-04 | 14 | 7 | 2 | HP:0012304 | |
| HumanPheno | Social and occupational deterioration | 1.69e-04 | 15 | 7 | 2 | HP:0007086 | |
| HumanPheno | Duplication of phalanx of toe | 1.69e-04 | 15 | 7 | 2 | HP:0010181 | |
| HumanPheno | Square face | 1.92e-04 | 16 | 7 | 2 | HP:0000321 | |
| HumanPheno | Premature thelarche | 2.18e-04 | 17 | 7 | 2 | HP:0010314 | |
| HumanPheno | Wide anterior fontanel | 2.36e-04 | 99 | 7 | 3 | HP:0000260 | |
| HumanPheno | Facial hirsutism | 2.45e-04 | 18 | 7 | 2 | HP:0009937 | |
| HumanPheno | Skin appendage neoplasm | 2.45e-04 | 18 | 7 | 2 | HP:0012842 | |
| HumanPheno | Absent earlobe | 3.04e-04 | 20 | 7 | 2 | HP:0000387 | |
| HumanPheno | Localized hirsutism | 3.36e-04 | 21 | 7 | 2 | HP:0009889 | |
| HumanPheno | Deep plantar creases | 3.36e-04 | 21 | 7 | 2 | HP:0001869 | |
| HumanPheno | Corneal scarring | 3.36e-04 | 21 | 7 | 2 | HP:0000559 | |
| HumanPheno | Abnormal size of the palpebral fissures | 3.49e-04 | 298 | 7 | 4 | HP:0200007 | |
| HumanPheno | Adducted thumb | 3.58e-04 | 114 | 7 | 3 | HP:0001181 | |
| HumanPheno | Abnormal foramen magnum morphology | 4.04e-04 | 23 | 7 | 2 | HP:0002699 | |
| HumanPheno | Agenesis of permanent teeth | 4.04e-04 | 23 | 7 | 2 | HP:0006349 | |
| HumanPheno | Chronic constipation | 4.16e-04 | 120 | 7 | 3 | HP:0012450 | |
| HumanPheno | Simple ear | 4.40e-04 | 24 | 7 | 2 | HP:0020206 | |
| HumanPheno | Broad hallux phalanx | 4.40e-04 | 24 | 7 | 2 | HP:0010059 | |
| HumanPheno | Mitral valve prolapse | 4.48e-04 | 123 | 7 | 3 | HP:0001634 | |
| HumanPheno | Shawl scrotum | 4.78e-04 | 25 | 7 | 2 | HP:0000049 | |
| HumanPheno | Hypoplasia of teeth | 4.81e-04 | 126 | 7 | 3 | HP:0000685 | |
| HumanPheno | Toe deformity | 5.16e-04 | 129 | 7 | 3 | HP:0034398 | |
| HumanPheno | Blepharophimosis | 5.16e-04 | 129 | 7 | 3 | HP:0000581 | |
| HumanPheno | Minor feet anomalies | 5.18e-04 | 26 | 7 | 2 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 5.18e-04 | 26 | 7 | 2 | HP:0010611 | |
| HumanPheno | Phonophobia | 5.18e-04 | 26 | 7 | 2 | HP:0002183 | |
| HumanPheno | Perimembranous ventricular septal defect | 5.18e-04 | 26 | 7 | 2 | HP:0011682 | |
| HumanPheno | Flared iliac wing | 5.59e-04 | 27 | 7 | 2 | HP:0002869 | |
| HumanPheno | Broad distal phalanx of finger | 5.59e-04 | 27 | 7 | 2 | HP:0009836 | |
| HumanPheno | Abnormal anterior fontanelle morphology | 6.02e-04 | 136 | 7 | 3 | HP:0000236 | |
| HumanPheno | Short columella | 6.46e-04 | 29 | 7 | 2 | HP:0002000 | |
| HumanPheno | Abnormal parietal bone morphology | 6.46e-04 | 29 | 7 | 2 | HP:0002696 | |
| HumanPheno | Broad eyebrow | 6.46e-04 | 29 | 7 | 2 | HP:0011229 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 6.91e-04 | 30 | 7 | 2 | HP:0005743 | |
| HumanPheno | Abnormal epididymis morphology | 6.91e-04 | 30 | 7 | 2 | HP:0009714 | |
| HumanPheno | Preaxial foot polydactyly | 6.91e-04 | 30 | 7 | 2 | HP:0001841 | |
| HumanPheno | Dental crowding | 7.12e-04 | 144 | 7 | 3 | HP:0000678 | |
| HumanPheno | Hypoplastic iliac wing | 7.39e-04 | 31 | 7 | 2 | HP:0002866 | |
| HumanPheno | Abnormal mitral valve morphology | 7.42e-04 | 146 | 7 | 3 | HP:0031477 | |
| HumanPheno | Impulsivity | 7.87e-04 | 149 | 7 | 3 | HP:0100710 | |
| HumanPheno | Frontal upsweep of hair | 8.38e-04 | 33 | 7 | 2 | HP:0002236 | |
| HumanPheno | Syringomyelia | 8.38e-04 | 33 | 7 | 2 | HP:0003396 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 8.38e-04 | 33 | 7 | 2 | HP:0011587 | |
| HumanPheno | Aspiration | 8.89e-04 | 34 | 7 | 2 | HP:0002835 | |
| HumanPheno | Dental malocclusion | 9.01e-04 | 156 | 7 | 3 | HP:0000689 | |
| HumanPheno | Abnormal number of permanent teeth | 9.43e-04 | 35 | 7 | 2 | HP:0011044 | |
| HumanPheno | Hydrocele testis | 9.97e-04 | 36 | 7 | 2 | HP:0000034 | |
| HumanPheno | Disturbance of facial expression | 9.97e-04 | 36 | 7 | 2 | HP:0005324 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 9.97e-04 | 36 | 7 | 2 | HP:0009617 | |
| HumanPheno | Nasolacrimal duct obstruction | 9.97e-04 | 36 | 7 | 2 | HP:0000579 | |
| HumanPheno | Abnormal pulmonary valve physiology | 1.02e-03 | 163 | 7 | 3 | HP:0031654 | |
| HumanPheno | Auditory sensitivity | 1.05e-03 | 37 | 7 | 2 | HP:0025112 | |
| HumanPheno | Accessory spleen | 1.05e-03 | 37 | 7 | 2 | HP:0001747 | |
| HumanPheno | Auditory hypersensitivity | 1.05e-03 | 37 | 7 | 2 | HP:5200060 | |
| HumanPheno | Nasogastric tube feeding in infancy | 1.05e-03 | 37 | 7 | 2 | HP:0011470 | |
| HumanPheno | Natal tooth | 1.11e-03 | 38 | 7 | 2 | HP:0000695 | |
| HumanPheno | Abnormal heart valve physiology | 1.11e-03 | 403 | 7 | 4 | HP:0031653 | |
| HumanPheno | Sleep apnea | 1.12e-03 | 168 | 7 | 3 | HP:0010535 | |
| HumanPheno | Sleep-related breathing disorders | 1.14e-03 | 169 | 7 | 3 | HP:5200283 | |
| HumanPheno | Capillary hemangioma | 1.17e-03 | 39 | 7 | 2 | HP:0005306 | |
| HumanPheno | Cellular immunodeficiency | 1.17e-03 | 39 | 7 | 2 | HP:0005374 | |
| HumanPheno | Poor coordination | 1.17e-03 | 39 | 7 | 2 | HP:0002370 | |
| HumanPheno | Large fontanelles | 1.28e-03 | 176 | 7 | 3 | HP:0000239 | |
| HumanPheno | Abnormal hair whorl | 1.36e-03 | 42 | 7 | 2 | HP:0010721 | |
| HumanPheno | Juvenile aseptic necrosis | 1.42e-03 | 43 | 7 | 2 | HP:0100323 | |
| MousePheno | ventricle myocardium hypoplasia | 4.28e-08 | 71 | 20 | 5 | MP:0010502 | |
| MousePheno | myocardium hypoplasia | 1.13e-07 | 86 | 20 | 5 | MP:0010500 | |
| MousePheno | ventricular hypoplasia | 2.29e-07 | 99 | 20 | 5 | MP:0000279 | |
| MousePheno | heart hypoplasia | 2.80e-07 | 103 | 20 | 5 | MP:0002740 | |
| MousePheno | thin myocardium compact layer | 4.78e-07 | 46 | 20 | 4 | MP:0004057 | |
| MousePheno | abnormal ventricle myocardium morphology | 5.06e-07 | 116 | 20 | 5 | MP:0010499 | |
| MousePheno | abnormal myocardium compact layer morphology | 2.20e-06 | 67 | 20 | 4 | MP:0004056 | |
| MousePheno | thin ventricle myocardium compact layer | 2.81e-06 | 20 | 20 | 3 | MP:0010556 | |
| MousePheno | thin ventricular wall | 3.90e-05 | 138 | 20 | 4 | MP:0000280 | |
| MousePheno | effusion | 5.68e-05 | 152 | 20 | 4 | MP:0021205 | |
| MousePheno | small heart | 7.22e-05 | 321 | 20 | 5 | MP:0002188 | |
| MousePheno | abnormal interventricular septum morphology | 9.75e-05 | 342 | 20 | 5 | MP:0000281 | |
| MousePheno | abnormal neural tube morphology | 1.30e-04 | 591 | 20 | 6 | MP:0002151 | |
| MousePheno | abnormal heart septum morphology | 1.76e-04 | 388 | 20 | 5 | MP:0006113 | |
| MousePheno | abnormal trabecula carnea morphology | 1.78e-04 | 78 | 20 | 3 | MP:0004067 | |
| MousePheno | abnormal megakaryocyte morphology | 2.38e-04 | 86 | 20 | 3 | MP:0002417 | |
| MousePheno | abnormal myocardium layer morphology | 2.39e-04 | 414 | 20 | 5 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 2.61e-04 | 422 | 20 | 5 | MP:0010545 | |
| MousePheno | abnormal heart ventricle wall thickness | 2.67e-04 | 227 | 20 | 4 | MP:0020135 | |
| MousePheno | perimembraneous ventricular septal defect | 2.90e-04 | 92 | 20 | 3 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 2.99e-04 | 93 | 20 | 3 | MP:0008823 | |
| MousePheno | abnormal bone marrow hematopoietic cell morphology | 3.93e-04 | 102 | 20 | 3 | MP:0013660 | |
| MousePheno | ventricular septal defect | 4.55e-04 | 261 | 20 | 4 | MP:0010402 | |
| MousePheno | pericardial effusion | 5.03e-04 | 111 | 20 | 3 | MP:0005312 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 5.14e-04 | 489 | 20 | 5 | MP:0010630 | |
| MousePheno | abnormal fibroblast physiology | 5.24e-04 | 271 | 20 | 4 | MP:0020414 | |
| MousePheno | abnormal lung morphology | 5.34e-04 | 767 | 20 | 6 | MP:0001175 | |
| MousePheno | abnormal embryonic tissue morphology | 6.22e-04 | 1116 | 20 | 7 | MP:0002085 | |
| MousePheno | abnormal prenatal body size | 6.22e-04 | 1116 | 20 | 7 | MP:0010866 | |
| MousePheno | abnormal heart ventricle morphology | 6.38e-04 | 793 | 20 | 6 | MP:0005294 | |
| MousePheno | perinatal lethality | 6.71e-04 | 1130 | 20 | 7 | MP:0002081 | |
| MousePheno | abnormal heart ventricle wall morphology | 7.30e-04 | 296 | 20 | 4 | MP:0031532 | |
| MousePheno | decreased thymocyte number | 7.46e-04 | 127 | 20 | 3 | MP:0000715 | |
| MousePheno | abnormal fluid regulation | 7.91e-04 | 826 | 20 | 6 | MP:0001784 | |
| MousePheno | abnormal heart size | 8.71e-04 | 1180 | 20 | 7 | MP:0005406 | |
| MousePheno | abnormal vascular endothelial cell development | 8.82e-04 | 31 | 20 | 2 | MP:0003542 | |
| MousePheno | abnormal lung development | 1.03e-03 | 142 | 20 | 3 | MP:0001176 | |
| MousePheno | abnormal myocardial trabeculae morphology | 1.07e-03 | 144 | 20 | 3 | MP:0002189 | |
| MousePheno | abnormal nervous system development | 1.27e-03 | 1257 | 20 | 7 | MP:0003861 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.34e-03 | 1269 | 20 | 7 | MP:0011111 | |
| MousePheno | oligodactyly | 1.40e-03 | 39 | 20 | 2 | MP:0000565 | |
| MousePheno | abnormal premaxilla morphology | 1.40e-03 | 39 | 20 | 2 | MP:0002820 | |
| MousePheno | abnormal respiratory system development | 1.45e-03 | 160 | 20 | 3 | MP:0003115 | |
| MousePheno | abnormal embryo size | 1.70e-03 | 956 | 20 | 6 | MP:0001697 | |
| MousePheno | abnormal heart development | 1.71e-03 | 372 | 20 | 4 | MP:0000267 | |
| MousePheno | abnormal neural tube closure | 1.81e-03 | 378 | 20 | 4 | MP:0003720 | |
| MousePheno | increased megakaryocyte cell number | 1.86e-03 | 45 | 20 | 2 | MP:0008254 | |
| MousePheno | trabecula carnea hypoplasia | 1.94e-03 | 46 | 20 | 2 | MP:0000295 | |
| MousePheno | internal hemorrhage | 1.97e-03 | 387 | 20 | 4 | MP:0001634 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 2.11e-03 | 48 | 20 | 2 | MP:0003567 | |
| MousePheno | abnormal respiratory system morphology | 2.45e-03 | 1027 | 20 | 6 | MP:0002132 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 2.57e-03 | 700 | 20 | 5 | MP:0011098 | |
| MousePheno | abnormal vasculogenesis | 2.66e-03 | 54 | 20 | 2 | MP:0001622 | |
| MousePheno | abnormal fetal cardiomyocyte physiology | 2.76e-03 | 55 | 20 | 2 | MP:0011390 | |
| MousePheno | facial bone hypoplasia | 2.96e-03 | 57 | 20 | 2 | MP:0030386 | |
| MousePheno | lethality throughout fetal growth and development | 3.01e-03 | 435 | 20 | 4 | MP:0006208 | |
| MousePheno | myocardial trabeculae hypoplasia | 3.06e-03 | 58 | 20 | 2 | MP:0010503 | |
| MousePheno | abnormal sternocostal joint morphology | 3.38e-03 | 61 | 20 | 2 | MP:0008148 | |
| MousePheno | abnormal prenatal growth/weight/body size | 3.45e-03 | 1493 | 20 | 7 | MP:0004196 | |
| MousePheno | abnormal muscle morphology | 3.57e-03 | 1106 | 20 | 6 | MP:0002108 | |
| Domain | - | 1.58e-06 | 2 | 24 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.58e-06 | 2 | 24 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.58e-06 | 2 | 24 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.58e-06 | 2 | 24 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.58e-06 | 2 | 24 | 2 | PF08214 | |
| Domain | KIX | 1.58e-06 | 2 | 24 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.58e-06 | 2 | 24 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.58e-06 | 2 | 24 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.58e-06 | 2 | 24 | 2 | IPR013178 | |
| Domain | DUF902 | 1.58e-06 | 2 | 24 | 2 | PF06001 | |
| Domain | - | 1.58e-06 | 2 | 24 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.58e-06 | 2 | 24 | 2 | IPR010303 | |
| Domain | KAT11 | 1.58e-06 | 2 | 24 | 2 | SM01250 | |
| Domain | - | 1.58e-06 | 2 | 24 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 1.58e-06 | 2 | 24 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.58e-06 | 2 | 24 | 2 | IPR003101 | |
| Domain | Creb_binding | 1.58e-06 | 2 | 24 | 2 | PF09030 | |
| Domain | KIX | 1.58e-06 | 2 | 24 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.58e-06 | 2 | 24 | 2 | PS51727 | |
| Domain | Nuc_rcpt_coact | 2.37e-05 | 6 | 24 | 2 | IPR009110 | |
| Domain | TIL | 1.04e-04 | 12 | 24 | 2 | PF01826 | |
| Domain | C8 | 1.04e-04 | 12 | 24 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.22e-04 | 13 | 24 | 2 | IPR014853 | |
| Domain | C8 | 1.22e-04 | 13 | 24 | 2 | SM00832 | |
| Domain | TIL_dom | 1.43e-04 | 14 | 24 | 2 | IPR002919 | |
| Domain | VWFD | 1.88e-04 | 16 | 24 | 2 | PS51233 | |
| Domain | VWD | 1.88e-04 | 16 | 24 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.88e-04 | 16 | 24 | 2 | IPR001846 | |
| Domain | VWD | 1.88e-04 | 16 | 24 | 2 | PF00094 | |
| Domain | ZF_ZZ_2 | 2.39e-04 | 18 | 24 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.39e-04 | 18 | 24 | 2 | PS01357 | |
| Domain | ZZ | 2.39e-04 | 18 | 24 | 2 | PF00569 | |
| Domain | VWC_out | 2.67e-04 | 19 | 24 | 2 | SM00215 | |
| Domain | Znf_ZZ | 2.67e-04 | 19 | 24 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.67e-04 | 19 | 24 | 2 | SM00291 | |
| Domain | CT | 3.60e-04 | 22 | 24 | 2 | SM00041 | |
| Domain | Cys_knot_C | 4.66e-04 | 25 | 24 | 2 | IPR006207 | |
| Domain | CTCK_2 | 4.66e-04 | 25 | 24 | 2 | PS01225 | |
| Domain | Bromodomain_CS | 5.05e-04 | 26 | 24 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.03e-03 | 37 | 24 | 2 | PS00633 | |
| Domain | Bromodomain | 1.08e-03 | 38 | 24 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.26e-03 | 41 | 24 | 2 | PS50014 | |
| Domain | BROMO | 1.32e-03 | 42 | 24 | 2 | SM00297 | |
| Domain | Bromodomain | 1.32e-03 | 42 | 24 | 2 | IPR001487 | |
| Domain | - | 1.32e-03 | 42 | 24 | 2 | 1.20.920.10 | |
| Domain | VWF_dom | 1.32e-03 | 42 | 24 | 2 | IPR001007 | |
| Domain | NA-bd_OB-fold | 5.05e-03 | 83 | 24 | 2 | IPR012340 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.10e-08 | 140 | 19 | 6 | M27484 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.24e-08 | 7 | 19 | 3 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.16e-07 | 8 | 19 | 3 | M22058 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.09e-07 | 44 | 19 | 4 | M27295 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 9.35e-07 | 15 | 19 | 3 | MM1439 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.15e-06 | 16 | 19 | 3 | M27410 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.15e-06 | 16 | 19 | 3 | M8516 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.39e-06 | 17 | 19 | 3 | M27412 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.67e-06 | 18 | 19 | 3 | M26942 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.15e-06 | 22 | 19 | 3 | MM1370 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.61e-06 | 23 | 19 | 3 | M556 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.13e-06 | 24 | 19 | 3 | M13404 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 5.29e-06 | 26 | 19 | 3 | M2499 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.29e-06 | 26 | 19 | 3 | M27483 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.00e-05 | 32 | 19 | 3 | M39521 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.72e-05 | 5 | 19 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.72e-05 | 5 | 19 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.72e-05 | 5 | 19 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.72e-05 | 5 | 19 | 2 | M48023 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.99e-05 | 40 | 19 | 3 | MM15000 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.57e-05 | 6 | 19 | 2 | M22062 | |
| Pathway | PID_HNF3A_PATHWAY | 2.65e-05 | 44 | 19 | 3 | M285 | |
| Pathway | REACTOME_HEME_SIGNALING | 3.68e-05 | 49 | 19 | 3 | M41832 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 4.40e-05 | 52 | 19 | 3 | M2404 | |
| Pathway | PID_NFAT_3PATHWAY | 4.66e-05 | 53 | 19 | 3 | M113 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.80e-05 | 8 | 19 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.80e-05 | 8 | 19 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.80e-05 | 8 | 19 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 6.16e-05 | 9 | 19 | 2 | M47451 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 7.47e-05 | 62 | 19 | 3 | M546 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 7.70e-05 | 10 | 19 | 2 | M27945 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 8.21e-05 | 64 | 19 | 3 | M27046 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 8.60e-05 | 65 | 19 | 3 | M39682 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 9.40e-05 | 11 | 19 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 9.40e-05 | 11 | 19 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 9.40e-05 | 11 | 19 | 2 | M26924 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.84e-05 | 68 | 19 | 3 | M27303 | |
| Pathway | REACTOME_SUMOYLATION | 1.04e-04 | 189 | 19 | 4 | M27214 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.07e-04 | 70 | 19 | 3 | M938 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.13e-04 | 12 | 19 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.13e-04 | 12 | 19 | 2 | M27765 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.55e-04 | 14 | 19 | 2 | M27808 | |
| Pathway | PID_REG_GR_PATHWAY | 1.72e-04 | 82 | 19 | 3 | M115 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.79e-04 | 15 | 19 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.79e-04 | 15 | 19 | 2 | M10183 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.79e-04 | 15 | 19 | 2 | M953 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.85e-04 | 84 | 19 | 3 | M1008 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 2.04e-04 | 16 | 19 | 2 | MM1483 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.04e-04 | 16 | 19 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.04e-04 | 16 | 19 | 2 | MM1420 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 2.04e-04 | 16 | 19 | 2 | M27403 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.04e-04 | 16 | 19 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.04e-04 | 16 | 19 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.31e-04 | 17 | 19 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.31e-04 | 17 | 19 | 2 | M48025 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.34e-04 | 91 | 19 | 3 | M39700 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 2.39e-04 | 1022 | 19 | 7 | MM15436 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 2.60e-04 | 18 | 19 | 2 | M5290 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.90e-04 | 19 | 19 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.90e-04 | 19 | 19 | 2 | M46442 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 2.91e-04 | 98 | 19 | 3 | M48247 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.03e-04 | 250 | 19 | 4 | M27554 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.22e-04 | 20 | 19 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.56e-04 | 21 | 19 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.56e-04 | 21 | 19 | 2 | M27485 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.56e-04 | 21 | 19 | 2 | MM15706 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.91e-04 | 22 | 19 | 2 | MM1443 | |
| Pathway | REACTOME_ADIPOGENESIS | 4.09e-04 | 110 | 19 | 3 | M48259 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.20e-04 | 111 | 19 | 3 | M27416 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 4.28e-04 | 23 | 19 | 2 | M2821 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 4.40e-04 | 1128 | 19 | 7 | M1036 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.02e-04 | 118 | 19 | 3 | M27316 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.07e-04 | 25 | 19 | 2 | M27880 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 5.07e-04 | 25 | 19 | 2 | MM15546 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 5.28e-04 | 120 | 19 | 3 | M48233 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 5.49e-04 | 26 | 19 | 2 | M32 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 5.49e-04 | 26 | 19 | 2 | M47923 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 5.54e-04 | 122 | 19 | 3 | M29689 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 5.92e-04 | 27 | 19 | 2 | M26943 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 6.37e-04 | 28 | 19 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 7.32e-04 | 30 | 19 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 7.32e-04 | 30 | 19 | 2 | M936 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 8.61e-04 | 142 | 19 | 3 | M27233 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.79e-04 | 143 | 19 | 3 | M27275 | |
| Pathway | WP_CAMKK2_PATHWAY | 8.86e-04 | 33 | 19 | 2 | M40047 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 9.41e-04 | 34 | 19 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 9.41e-04 | 34 | 19 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 9.41e-04 | 34 | 19 | 2 | MM15531 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 9.41e-04 | 34 | 19 | 2 | M27826 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 9.90e-04 | 149 | 19 | 3 | M27888 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 9.97e-04 | 35 | 19 | 2 | M48246 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.03e-03 | 151 | 19 | 3 | M19428 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.03e-03 | 151 | 19 | 3 | M39801 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.06e-03 | 36 | 19 | 2 | M633 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.11e-03 | 37 | 19 | 2 | M27797 | |
| Pathway | PID_FRA_PATHWAY | 1.11e-03 | 37 | 19 | 2 | M65 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.18e-03 | 38 | 19 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.18e-03 | 38 | 19 | 2 | M27255 | |
| Pathway | PID_FOXM1_PATHWAY | 1.30e-03 | 40 | 19 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 1.30e-03 | 40 | 19 | 2 | M161 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 27633918 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 15380363 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 11912212 | ||
| Pubmed | 5.77e-09 | 6 | 24 | 3 | 12788643 | ||
| Pubmed | 5.77e-09 | 6 | 24 | 3 | 12569367 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 3.45e-08 | 10 | 24 | 3 | 30595551 | |
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 4.75e-08 | 11 | 24 | 3 | 15681609 | |
| Pubmed | 6.33e-08 | 12 | 24 | 3 | 12189208 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 1.05e-07 | 14 | 24 | 3 | 17641689 | |
| Pubmed | 1.95e-07 | 17 | 24 | 3 | 19183483 | ||
| Pubmed | 1.95e-07 | 17 | 24 | 3 | 28291835 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.34e-07 | 18 | 24 | 3 | 18834073 | |
| Pubmed | 2.78e-07 | 19 | 24 | 3 | 16204234 | ||
| Pubmed | 3.27e-07 | 20 | 24 | 3 | 11877444 | ||
| Pubmed | 3.81e-07 | 21 | 24 | 3 | 19596656 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 27881875 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.56e-07 | 2 | 24 | 2 | 11963968 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.56e-07 | 2 | 24 | 2 | 34845315 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.56e-07 | 2 | 24 | 2 | 34813504 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 19729597 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 15860545 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.56e-07 | 2 | 24 | 2 | 12696060 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 29460469 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 20301699 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.56e-07 | 2 | 24 | 2 | 24551300 | |
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.56e-07 | 2 | 24 | 2 | 36109165 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 15117818 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 24639469 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 37816914 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 12242694 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 33911074 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 9018065 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 24648406 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30135524 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.56e-07 | 2 | 24 | 2 | 11438528 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 10918613 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 31182547 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 35502657 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 39287984 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30635043 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 31898871 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.56e-07 | 2 | 24 | 2 | 16596650 | |
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.56e-07 | 2 | 24 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.56e-07 | 2 | 24 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.56e-07 | 2 | 24 | 2 | 27881443 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.56e-07 | 2 | 24 | 2 | 29217654 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 19272189 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.56e-07 | 2 | 24 | 2 | 37314181 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 20717166 | ||
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.56e-07 | 2 | 24 | 2 | 12397173 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 10049825 | ||
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.56e-07 | 2 | 24 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.56e-07 | 2 | 24 | 2 | 32690000 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 9733868 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30953353 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 21803292 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 9811832 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.56e-07 | 2 | 24 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.56e-07 | 2 | 24 | 2 | 29170789 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 24089570 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 25893291 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 11559821 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 21555743 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 4.56e-07 | 2 | 24 | 2 | 33063428 | |
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.56e-07 | 2 | 24 | 2 | 12646247 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 34506759 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 22177454 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 15706485 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 32576962 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 19822209 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 4.56e-07 | 2 | 24 | 2 | 39266679 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 24522976 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 22303793 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.56e-07 | 2 | 24 | 2 | 21847097 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 4.56e-07 | 2 | 24 | 2 | 34019788 | |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 5.07e-07 | 23 | 24 | 3 | 10235267 | |
| Pubmed | 9.35e-07 | 28 | 24 | 3 | 24880616 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 15598887 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 1.37e-06 | 3 | 24 | 2 | 14716005 | |
| Pubmed | The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. | 1.37e-06 | 3 | 24 | 2 | 25689462 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18070920 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 11973335 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 1.37e-06 | 3 | 24 | 2 | 21967847 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 9194564 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 15171256 | ||
| Pubmed | p300/CBP acts as a coactivator of the cone-rod homeobox transcription factor. | 1.37e-06 | 3 | 24 | 2 | 10708567 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16428436 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22523253 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 1.37e-06 | 3 | 24 | 2 | 11823864 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 1.37e-06 | 3 | 24 | 2 | 19252086 | |
| Pubmed | An essential role for p300/CBP in the cellular response to hypoxia. | 1.37e-06 | 3 | 24 | 2 | 8917528 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 19948376 | ||
| Pubmed | E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus. | 1.37e-06 | 3 | 24 | 2 | 22544934 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27903646 | ||
| Pubmed | Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. | 1.37e-06 | 3 | 24 | 2 | 10673499 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 12748286 | ||
| Interaction | TFF1 interactions | 1.52e-07 | 41 | 24 | 4 | int:TFF1 | |
| Interaction | CTBP1 interactions | 3.29e-07 | 406 | 24 | 7 | int:CTBP1 | |
| Interaction | SPI1 interactions | 1.13e-06 | 67 | 24 | 4 | int:SPI1 | |
| Interaction | GATA2 interactions | 3.26e-06 | 199 | 24 | 5 | int:GATA2 | |
| Interaction | FHL2 interactions | 5.53e-06 | 396 | 24 | 6 | int:FHL2 | |
| Interaction | ERG interactions | 5.68e-06 | 223 | 24 | 5 | int:ERG | |
| Interaction | PML interactions | 7.76e-06 | 933 | 24 | 8 | int:PML | |
| Interaction | KAT2B interactions | 1.11e-05 | 256 | 24 | 5 | int:KAT2B | |
| Interaction | KLF1 interactions | 1.12e-05 | 37 | 24 | 3 | int:KLF1 | |
| Interaction | RORA interactions | 1.32e-05 | 39 | 24 | 3 | int:RORA | |
| Interaction | HNF4A interactions | 1.57e-05 | 275 | 24 | 5 | int:HNF4A | |
| Interaction | NFE2L2 interactions | 3.51e-05 | 159 | 24 | 4 | int:NFE2L2 | |
| Interaction | CIITA interactions | 3.74e-05 | 55 | 24 | 3 | int:CIITA | |
| Interaction | NFATC1 interactions | 4.35e-05 | 168 | 24 | 4 | int:NFATC1 | |
| Interaction | GATA1 interactions | 4.66e-05 | 171 | 24 | 4 | int:GATA1 | |
| Interaction | HOXB6 interactions | 4.86e-05 | 60 | 24 | 3 | int:HOXB6 | |
| Interaction | HOXB3 interactions | 4.87e-05 | 9 | 24 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 4.87e-05 | 9 | 24 | 2 | int:ARGFX | |
| Interaction | MAPK14 interactions | 5.18e-05 | 353 | 24 | 5 | int:MAPK14 | |
| Interaction | SMARCC2 interactions | 5.18e-05 | 353 | 24 | 5 | int:SMARCC2 | |
| Interaction | HOXA10 interactions | 5.36e-05 | 62 | 24 | 3 | int:HOXA10 | |
| Interaction | KAT2A interactions | 5.69e-05 | 180 | 24 | 4 | int:KAT2A | |
| Interaction | GATA3 interactions | 6.60e-05 | 187 | 24 | 4 | int:GATA3 | |
| Interaction | TLE3 interactions | 6.98e-05 | 376 | 24 | 5 | int:TLE3 | |
| Interaction | SMARCC1 interactions | 7.72e-05 | 384 | 24 | 5 | int:SMARCC1 | |
| Interaction | EGR1 interactions | 8.39e-05 | 72 | 24 | 3 | int:EGR1 | |
| Interaction | NFATC2 interactions | 8.56e-05 | 200 | 24 | 4 | int:NFATC2 | |
| Interaction | MAML1 interactions | 8.74e-05 | 73 | 24 | 3 | int:MAML1 | |
| Interaction | FEV interactions | 9.07e-05 | 203 | 24 | 4 | int:FEV | |
| Interaction | PARP1 interactions | 9.26e-05 | 1316 | 24 | 8 | int:PARP1 | |
| Interaction | UBE2I interactions | 9.32e-05 | 654 | 24 | 6 | int:UBE2I | |
| Interaction | TGS1 interactions | 9.47e-05 | 75 | 24 | 3 | int:TGS1 | |
| Interaction | PCGF1 interactions | 9.96e-05 | 208 | 24 | 4 | int:PCGF1 | |
| Interaction | NR3C1 interactions | 1.01e-04 | 974 | 24 | 7 | int:NR3C1 | |
| Interaction | HSF2 interactions | 1.11e-04 | 79 | 24 | 3 | int:HSF2 | |
| Interaction | RFX1 interactions | 1.19e-04 | 81 | 24 | 3 | int:RFX1 | |
| Interaction | WWTR1 interactions | 1.20e-04 | 422 | 24 | 5 | int:WWTR1 | |
| Interaction | NUP35 interactions | 1.23e-04 | 424 | 24 | 5 | int:NUP35 | |
| Interaction | PPARGC1A interactions | 1.24e-04 | 82 | 24 | 3 | int:PPARGC1A | |
| Interaction | SOX7 interactions | 1.24e-04 | 82 | 24 | 3 | int:SOX7 | |
| Interaction | RARA interactions | 1.30e-04 | 223 | 24 | 4 | int:RARA | |
| Interaction | H2BC21 interactions | 1.31e-04 | 696 | 24 | 6 | int:H2BC21 | |
| Interaction | NCOA3 interactions | 1.33e-04 | 224 | 24 | 4 | int:NCOA3 | |
| Interaction | KLF2 interactions | 1.41e-04 | 15 | 24 | 2 | int:KLF2 | |
| Interaction | EP300 interactions | 1.44e-04 | 1401 | 24 | 8 | int:EP300 | |
| Interaction | CSNK2A2 interactions | 1.56e-04 | 718 | 24 | 6 | int:CSNK2A2 | |
| Interaction | TFAP2D interactions | 1.58e-04 | 89 | 24 | 3 | int:TFAP2D | |
| Interaction | PCGF3 interactions | 1.63e-04 | 90 | 24 | 3 | int:PCGF3 | |
| Interaction | DYRK1B interactions | 1.68e-04 | 91 | 24 | 3 | int:DYRK1B | |
| Interaction | YY1 interactions | 1.69e-04 | 454 | 24 | 5 | int:YY1 | |
| Interaction | MAML2 interactions | 1.83e-04 | 17 | 24 | 2 | int:MAML2 | |
| Interaction | CDC16 interactions | 1.90e-04 | 246 | 24 | 4 | int:CDC16 | |
| Interaction | JUN interactions | 1.99e-04 | 470 | 24 | 5 | int:JUN | |
| Interaction | SOX9 interactions | 2.03e-04 | 97 | 24 | 3 | int:SOX9 | |
| Interaction | NEMF interactions | 2.10e-04 | 98 | 24 | 3 | int:NEMF | |
| Interaction | TBP interactions | 2.11e-04 | 253 | 24 | 4 | int:TBP | |
| Interaction | CREB1 interactions | 2.15e-04 | 254 | 24 | 4 | int:CREB1 | |
| Interaction | NEUROG1 interactions | 2.30e-04 | 19 | 24 | 2 | int:NEUROG1 | |
| Interaction | DBP interactions | 2.30e-04 | 19 | 24 | 2 | int:DBP | |
| Interaction | FBRS interactions | 2.36e-04 | 102 | 24 | 3 | int:FBRS | |
| Interaction | KDM2A interactions | 2.43e-04 | 103 | 24 | 3 | int:KDM2A | |
| Interaction | KYAT1 interactions | 2.55e-04 | 20 | 24 | 2 | int:KYAT1 | |
| Interaction | SPIB interactions | 2.55e-04 | 20 | 24 | 2 | int:SPIB | |
| Interaction | TRRAP interactions | 2.61e-04 | 790 | 24 | 6 | int:TRRAP | |
| Interaction | CITED4 interactions | 2.82e-04 | 21 | 24 | 2 | int:CITED4 | |
| Interaction | HOXB4 interactions | 2.82e-04 | 21 | 24 | 2 | int:HOXB4 | |
| Interaction | PLAGL1 interactions | 2.82e-04 | 21 | 24 | 2 | int:PLAGL1 | |
| Interaction | KLF13 interactions | 2.82e-04 | 21 | 24 | 2 | int:KLF13 | |
| Interaction | HSD17B7P2 interactions | 2.82e-04 | 21 | 24 | 2 | int:HSD17B7P2 | |
| Interaction | ARID1A interactions | 2.95e-04 | 276 | 24 | 4 | int:ARID1A | |
| Interaction | PAX8 interactions | 3.03e-04 | 111 | 24 | 3 | int:PAX8 | |
| Interaction | THRA interactions | 3.03e-04 | 111 | 24 | 3 | int:THRA | |
| Interaction | CITED2 interactions | 3.39e-04 | 23 | 24 | 2 | int:CITED2 | |
| Interaction | HOXD10 interactions | 3.39e-04 | 23 | 24 | 2 | int:HOXD10 | |
| Interaction | SUMO1 interactions | 3.42e-04 | 287 | 24 | 4 | int:SUMO1 | |
| Interaction | TBXT interactions | 3.44e-04 | 116 | 24 | 3 | int:TBXT | |
| Interaction | JUNB interactions | 3.62e-04 | 118 | 24 | 3 | int:JUNB | |
| Interaction | TBX21 interactions | 3.69e-04 | 24 | 24 | 2 | int:TBX21 | |
| Interaction | CELA1 interactions | 3.69e-04 | 24 | 24 | 2 | int:CELA1 | |
| Interaction | CNTN2 interactions | 3.69e-04 | 24 | 24 | 2 | int:CNTN2 | |
| Interaction | NR6A1 interactions | 3.69e-04 | 24 | 24 | 2 | int:NR6A1 | |
| Interaction | NMNAT2 interactions | 4.01e-04 | 25 | 24 | 2 | int:NMNAT2 | |
| Interaction | ALX1 interactions | 4.01e-04 | 25 | 24 | 2 | int:ALX1 | |
| Interaction | TERF2IP interactions | 4.18e-04 | 552 | 24 | 5 | int:TERF2IP | |
| Interaction | FOXO3 interactions | 4.19e-04 | 124 | 24 | 3 | int:FOXO3 | |
| Interaction | PAX7 interactions | 4.19e-04 | 124 | 24 | 3 | int:PAX7 | |
| Interaction | SP7 interactions | 4.25e-04 | 304 | 24 | 4 | int:SP7 | |
| Interaction | ZDHHC15 interactions | 4.29e-04 | 125 | 24 | 3 | int:ZDHHC15 | |
| Interaction | HOXB7 interactions | 4.34e-04 | 26 | 24 | 2 | int:HOXB7 | |
| Interaction | VDR interactions | 4.49e-04 | 127 | 24 | 3 | int:VDR | |
| Interaction | UBE2Q2 interactions | 4.68e-04 | 27 | 24 | 2 | int:UBE2Q2 | |
| Interaction | FOS interactions | 4.69e-04 | 312 | 24 | 4 | int:FOS | |
| Interaction | ZBTB33 interactions | 4.70e-04 | 129 | 24 | 3 | int:ZBTB33 | |
| Interaction | PINX1 interactions | 4.81e-04 | 130 | 24 | 3 | int:PINX1 | |
| Interaction | GABPA interactions | 4.81e-04 | 130 | 24 | 3 | int:GABPA | |
| Interaction | RUNX1 interactions | 5.40e-04 | 324 | 24 | 4 | int:RUNX1 | |
| Interaction | ETV1 interactions | 5.41e-04 | 29 | 24 | 2 | int:ETV1 | |
| Interaction | ZYX interactions | 5.72e-04 | 329 | 24 | 4 | int:ZYX | |
| Interaction | KLF8 interactions | 5.72e-04 | 329 | 24 | 4 | int:KLF8 | |
| Interaction | HOXD4 interactions | 5.79e-04 | 30 | 24 | 2 | int:HOXD4 | |
| Cytoband | 17q12 | 1.23e-03 | 99 | 24 | 2 | 17q12 | |
| Cytoband | 11p15.5 | 1.74e-03 | 118 | 24 | 2 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 2.76e-03 | 149 | 24 | 2 | chr17q12 | |
| GeneFamily | CD molecules|Mucins | 1.77e-06 | 21 | 21 | 3 | 648 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.73e-04 | 17 | 21 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.94e-04 | 18 | 21 | 2 | 91 | |
| GeneFamily | PDZ domain containing | 1.33e-02 | 152 | 21 | 2 | 1220 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.82e-06 | 186 | 24 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-06 | 192 | 24 | 4 | c6795ceba90f1a5d441dff92a737b9c7d28b06b0 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-06 | 192 | 24 | 4 | 5d24bb6c6c17a6b803b241d065b31896a7d86c37 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Trm_Th1/Th17|blood / Manually curated celltypes from each tissue | 7.41e-05 | 153 | 24 | 3 | d09bc7322b59f613d66673359ee6af1aea99ce87 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.46e-05 | 160 | 24 | 3 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | Club_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.43e-05 | 166 | 24 | 3 | a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 170 | 24 | 3 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 177 | 24 | 3 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | (7)_Epithelial-G_(Club-Clara_cells)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.41e-04 | 190 | 24 | 3 | 593fd1451038b155826a48de4caa38f44406d0b9 | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-04 | 191 | 24 | 3 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.45e-04 | 192 | 24 | 3 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 1.45e-04 | 192 | 24 | 3 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.45e-04 | 192 | 24 | 3 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.45e-04 | 192 | 24 | 3 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 193 | 24 | 3 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 193 | 24 | 3 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-04 | 193 | 24 | 3 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-04 | 193 | 24 | 3 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 194 | 24 | 3 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.52e-04 | 195 | 24 | 3 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 195 | 24 | 3 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.52e-04 | 195 | 24 | 3 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.52e-04 | 195 | 24 | 3 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.52e-04 | 195 | 24 | 3 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.56e-04 | 197 | 24 | 3 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Serous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | 92a66e3b5ddc3d55527c31e0d9cff15c2203ecfc | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-04 | 198 | 24 | 3 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 199 | 24 | 3 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.63e-04 | 200 | 24 | 3 | 5e2def2e56f21bc7295cdcf3580f5c0d16a6a494 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.63e-04 | 200 | 24 | 3 | 07408011b37d32a20164866cf5da9dd120985357 | |
| ToppCell | Club-club-11|World / Class top | 3.98e-04 | 55 | 24 | 2 | d1d832e1c98a89e2b461127922c3e4d7f42d7401 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.19e-03 | 130 | 24 | 2 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.23e-03 | 131 | 24 | 2 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-03 | 138 | 24 | 2 | c172880eda7b8b8b758dbbc77f93191238f3181c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.50e-03 | 139 | 24 | 2 | 313f7e66ed94950129c7146a2afe2feb8951fe1e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-03 | 140 | 24 | 2 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | Severe-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.54e-03 | 140 | 24 | 2 | 683ee5e103f0c68cbbec019249404d381dbc39f3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-03 | 143 | 24 | 2 | 39060dc1d87505a16e2df95140087c731f099570 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-03 | 144 | 24 | 2 | 163c591fedad2beb7f92531e6240e9554f90ea40 | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.68e-03 | 144 | 24 | 2 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.79e-03 | 147 | 24 | 2 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | Tuft-tuft-3|World / Class top | 2.83e-03 | 148 | 24 | 2 | f4f59b46a79fc9aa4c5d330a7b37b1a34a6d71cc | |
| ToppCell | VE-CD8-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.83e-03 | 148 | 24 | 2 | f49f579650b57cc4c6c7a7fa726447740d3dc695 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-03 | 149 | 24 | 2 | aedbae2dffa1e880e5c6a146b6d5a135e7f54308 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.87e-03 | 149 | 24 | 2 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-03 | 150 | 24 | 2 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | COVID-19_Mild-PLT_5|World / Disease Group and Platelet Clusters | 2.98e-03 | 152 | 24 | 2 | 90ba4e8a735ec8921038fa072129535f0e3fd9ae | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-03 | 153 | 24 | 2 | 9f0607a88d5f8a2c128a2ff64dfbc986212f13b2 | |
| ToppCell | COVID-Treg-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 3.02e-03 | 153 | 24 | 2 | 47c649fd4231e507f2d4654ccac61faf21a04eff | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-03 | 155 | 24 | 2 | 8dab23aad905cc35a35643baa0554acb3f6fe6c8 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-03 | 155 | 24 | 2 | 42533beaded07068f00540de704de07e4f19abcf | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.10e-03 | 155 | 24 | 2 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-03 | 157 | 24 | 2 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.18e-03 | 157 | 24 | 2 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.18e-03 | 157 | 24 | 2 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-03 | 157 | 24 | 2 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.18e-03 | 157 | 24 | 2 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-03 | 157 | 24 | 2 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-03 | 157 | 24 | 2 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.21e-03 | 158 | 24 | 2 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.25e-03 | 159 | 24 | 2 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.29e-03 | 160 | 24 | 2 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-03 | 160 | 24 | 2 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.29e-03 | 160 | 24 | 2 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 3.29e-03 | 160 | 24 | 2 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.34e-03 | 161 | 24 | 2 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T7|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.38e-03 | 162 | 24 | 2 | c6ace47daf32495b25793d39b72382978349597d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.42e-03 | 163 | 24 | 2 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-03 | 165 | 24 | 2 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-03 | 165 | 24 | 2 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-03 | 165 | 24 | 2 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.50e-03 | 165 | 24 | 2 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.50e-03 | 165 | 24 | 2 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-03 | 166 | 24 | 2 | eb9c81fa7573de7aff6670e7dad313f02129809f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-03 | 167 | 24 | 2 | 166b7b4ca0663cde6d88219ee0bcc1988d03dab8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-03 | 168 | 24 | 2 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.67e-03 | 169 | 24 | 2 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-03 | 169 | 24 | 2 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-03 | 169 | 24 | 2 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.67e-03 | 169 | 24 | 2 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-03 | 169 | 24 | 2 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-03 | 170 | 24 | 2 | 0c9d38e89b048166b879e6b4bdf7c5dfe8ab57c4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.71e-03 | 170 | 24 | 2 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.71e-03 | 170 | 24 | 2 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-03 | 170 | 24 | 2 | 330b5fc8fde307eda9dcc7bc9053ea8a7e1f0f6d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-03 | 171 | 24 | 2 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-03 | 171 | 24 | 2 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-03 | 171 | 24 | 2 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-03 | 171 | 24 | 2 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.75e-03 | 171 | 24 | 2 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 1.71e-06 | 197 | 24 | 5 | 7171_DN | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A | 1.85e-06 | 200 | 24 | 5 | 1922_UP | |
| Drug | AC1L9K70 | 3.51e-06 | 228 | 24 | 5 | CID000446871 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.06e-05 | 5 | 24 | 2 | ctd:C575894 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.84e-05 | 170 | 24 | 4 | 3791_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.97e-05 | 172 | 24 | 4 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.97e-05 | 172 | 24 | 4 | 2794_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.55e-05 | 180 | 24 | 4 | 6886_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.55e-05 | 180 | 24 | 4 | 4541_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 4.29e-05 | 189 | 24 | 4 | 5084_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 4.75e-05 | 194 | 24 | 4 | 4105_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HG-U133A | 4.75e-05 | 194 | 24 | 4 | 409_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 5827_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A | 4.95e-05 | 196 | 24 | 4 | 1958_UP | |
| Drug | sodium 4-phenylbutyrate; Up 200; 1000uM; HL60; HG-U133A | 4.95e-05 | 196 | 24 | 4 | 411_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 7432_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 5285_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; HL60; HG-U133A | 5.04e-05 | 197 | 24 | 4 | 1578_UP | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 4553_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 7231_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; PC3; HG-U133A | 5.04e-05 | 197 | 24 | 4 | 1925_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HG-U133A | 5.14e-05 | 198 | 24 | 4 | 1910_UP | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.14e-05 | 198 | 24 | 4 | 7035_UP | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; PC3; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 7289_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 7184_DN | |
| Drug | WY-14643; Up 200; 100uM; PC3; HG-U133A | 5.35e-05 | 200 | 24 | 4 | 481_UP | |
| Drug | AC1L9FY1 | 1.60e-04 | 101 | 24 | 3 | CID000444218 | |
| Drug | 4,4'-DBP | 1.80e-04 | 19 | 24 | 2 | CID000007034 | |
| Drug | a-X-d | 2.43e-04 | 22 | 24 | 2 | CID011987862 | |
| Drug | mobs | 2.43e-04 | 22 | 24 | 2 | CID003674064 | |
| Drug | thymine | 3.07e-04 | 315 | 24 | 4 | CID000001135 | |
| Drug | A-skin | 5.18e-04 | 32 | 24 | 2 | CID000208772 | |
| Drug | Nexus | 5.33e-04 | 152 | 24 | 3 | CID000098527 | |
| Drug | prochloraz | 5.64e-04 | 155 | 24 | 3 | CID000073665 | |
| Drug | fullerene C60 | 6.74e-04 | 1498 | 24 | 7 | ctd:C069837 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.88e-04 | 166 | 24 | 3 | 2268_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.13e-04 | 168 | 24 | 3 | 3868_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.38e-04 | 170 | 24 | 3 | 1050_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.50e-04 | 171 | 24 | 3 | 6879_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.50e-04 | 171 | 24 | 3 | 4954_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.63e-04 | 172 | 24 | 3 | 6993_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 7.89e-04 | 174 | 24 | 3 | 7530_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.89e-04 | 174 | 24 | 3 | 5065_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.02e-04 | 175 | 24 | 3 | 1014_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.02e-04 | 175 | 24 | 3 | 1058_DN | |
| Drug | 2,6-dihydroxybenzoic acid | 8.02e-04 | 175 | 24 | 3 | CID000009338 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.29e-04 | 177 | 24 | 3 | 1645_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.29e-04 | 177 | 24 | 3 | 6972_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.29e-04 | 177 | 24 | 3 | 6434_DN | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.29e-04 | 177 | 24 | 3 | 841_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.29e-04 | 177 | 24 | 3 | 7047_DN | |
| Drug | 5182598; Up 200; 25uM; MCF7; HT_HG-U133A_EA | 8.29e-04 | 177 | 24 | 3 | 976_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.43e-04 | 178 | 24 | 3 | 992_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.43e-04 | 178 | 24 | 3 | 1112_DN | |
| Drug | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 8.52e-04 | 41 | 24 | 2 | ctd:D019307 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.56e-04 | 179 | 24 | 3 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.56e-04 | 179 | 24 | 3 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.70e-04 | 180 | 24 | 3 | 3688_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.70e-04 | 180 | 24 | 3 | 4821_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.84e-04 | 181 | 24 | 3 | 7005_DN | |
| Drug | N-methylmesoporphyrin | 8.94e-04 | 42 | 24 | 2 | CID000444708 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.99e-04 | 182 | 24 | 3 | 3887_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 8.99e-04 | 182 | 24 | 3 | 6896_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 9.13e-04 | 183 | 24 | 3 | 7498_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | 9.13e-04 | 183 | 24 | 3 | 4527_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 9.42e-04 | 185 | 24 | 3 | 2949_UP | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 3677_UP | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 6764_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 3077_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 9.87e-04 | 188 | 24 | 3 | 5116_DN | |
| Drug | Alsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A | 9.87e-04 | 188 | 24 | 3 | 7078_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.00e-03 | 189 | 24 | 3 | 6997_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 7070_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 2721_UP | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.03e-03 | 191 | 24 | 3 | 6721_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.03e-03 | 191 | 24 | 3 | 3392_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A | 1.03e-03 | 191 | 24 | 3 | 3665_DN | |
| Drug | Niclosamide | 1.03e-03 | 191 | 24 | 3 | ctd:D009534 | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 3164_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 4274_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 3114_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 4146_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 5232_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A | 1.06e-03 | 193 | 24 | 3 | 1412_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 7364_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 7232_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 1217_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 6368_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 6761_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 6738_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 6893_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 1642_DN | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; PC3; HG-U133A | 1.08e-03 | 194 | 24 | 3 | 1954_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 3774_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 7196_DN | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 4325_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 4379_UP | |
| Drug | 1,5-Isoquinolinediol; Down 200; 100uM; HL60; HG-U133A | 1.10e-03 | 195 | 24 | 3 | 543_DN | |
| Disease | Menke-Hennekam syndrome | 5.81e-07 | 2 | 23 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 5.81e-07 | 2 | 23 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 5.81e-07 | 2 | 23 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.81e-07 | 2 | 23 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 5.81e-07 | 2 | 23 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.81e-07 | 2 | 23 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 5.81e-07 | 2 | 23 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 5.81e-07 | 2 | 23 | 2 | C0035934 | |
| Disease | Adenoid Cystic Carcinoma | 6.37e-05 | 100 | 23 | 3 | C0010606 | |
| Disease | oral motor function measurement | 7.85e-05 | 17 | 23 | 2 | EFO_0021793 | |
| Disease | Carcinoma, Transitional Cell | 4.68e-04 | 41 | 23 | 2 | C0007138 | |
| Disease | Small cell carcinoma of lung | 8.11e-04 | 54 | 23 | 2 | C0149925 | |
| Disease | Diffuse Large B-Cell Lymphoma | 8.42e-04 | 55 | 23 | 2 | C0079744 | |
| Disease | idiopathic pulmonary fibrosis | 9.04e-04 | 57 | 23 | 2 | EFO_0000768 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.03e-03 | 61 | 23 | 2 | C1961102 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.14e-03 | 64 | 23 | 2 | DOID:4947 (is_marker_for) | |
| Disease | hair colour measurement | 1.21e-03 | 615 | 23 | 4 | EFO_0007822 | |
| Disease | citrate measurement | 1.73e-03 | 79 | 23 | 2 | EFO_0010114 | |
| Disease | Squamous cell carcinoma of esophagus | 2.48e-03 | 95 | 23 | 2 | C0279626 | |
| Disease | testosterone measurement | 2.62e-03 | 1275 | 23 | 5 | EFO_0004908 | |
| Disease | systemic lupus erythematosus | 3.13e-03 | 799 | 23 | 4 | MONDO_0007915 | |
| Disease | creatinine measurement, glomerular filtration rate | 3.73e-03 | 117 | 23 | 2 | EFO_0004518, EFO_0005208 | |
| Disease | Squamous cell carcinoma | 4.18e-03 | 124 | 23 | 2 | C0007137 | |
| Disease | prostate carcinoma | 4.63e-03 | 891 | 23 | 4 | EFO_0001663 | |
| Disease | Global developmental delay | 4.79e-03 | 133 | 23 | 2 | C0557874 | |
| Disease | blood urea nitrogen measurement | 5.04e-03 | 452 | 23 | 3 | EFO_0004741 | |
| Disease | Bladder Neoplasm | 5.30e-03 | 140 | 23 | 2 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 5.37e-03 | 141 | 23 | 2 | C0005684 | |
| Disease | complement factor H-related protein 3 measurement | 7.62e-03 | 169 | 23 | 2 | EFO_0600056 | |
| Disease | empathy measurement | 7.71e-03 | 170 | 23 | 2 | EFO_0009183 | |
| Disease | Leukemia, Myelocytic, Acute | 7.97e-03 | 173 | 23 | 2 | C0023467 | |
| Disease | urinary albumin to creatinine ratio | 8.52e-03 | 179 | 23 | 2 | EFO_0007778 | |
| Disease | serum urea measurement | 1.00e-02 | 195 | 23 | 2 | EFO_0009795 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPSPVPSRTPTPHHT | 831 | Q09472 | |
| PSRTPTPHHTPPSIG | 836 | Q09472 | |
| HPSLPHSPLPSTVHS | 26 | Q13938 | |
| SSPSPRIQPQPSPHH | 2361 | Q92793 | |
| SVPSHTLPSHPVTPS | 591 | Q14155 | |
| SPHPSSRTTESPPSP | 2811 | Q9HC84 | |
| SPHPSSRTTESPPSP | 3511 | Q9HC84 | |
| AHSVISTRTPPPPSP | 351 | O00712 | |
| PTPSHPQTTLPTHVP | 1996 | Q6W4X9 | |
| NPPTPSSTPVSPLHH | 136 | P50549 | |
| HSPTPSPHGSPRVSV | 281 | O95644 | |
| PPPHSPSQSPTIIIH | 401 | Q8NDX5 | |
| SPSSHGPPATHPTSP | 286 | P35227 | |
| HPHTPQMPPSTPSSS | 481 | Q16666 | |
| SHPHTPQMPPSTPSS | 536 | Q16666 | |
| SVPPSPSLSRHSSPH | 641 | P13807 | |
| SSSATLPRPPHHAPP | 76 | Q99946 | |
| STIGSSPTPPHHTPP | 616 | Q15648 | |
| SPTPPHHTPPPVSSM | 621 | Q15648 | |
| TTPPYHSTLPPRAHP | 1521 | Q9P2F8 | |
| SPEEPPAPSHPHTSS | 741 | Q8TF72 | |
| VTPHFPTTPHPTTTP | 1171 | A1L4H1 | |
| PTTPHPTTTPHPTTI | 1176 | A1L4H1 | |
| TTTPHSTTPHPTTTP | 1231 | A1L4H1 | |
| STTPHPTTTPHPTTI | 1236 | A1L4H1 | |
| PTTMPHPTTTPHPTT | 1271 | A1L4H1 | |
| HPTTTPHPTTTPHPT | 1276 | A1L4H1 | |
| PHPTTTPHPTTTPHP | 1281 | A1L4H1 | |
| TPHPTTTPHPTTTPH | 1286 | A1L4H1 | |
| TTPHPTTTPHPTMTP | 1291 | A1L4H1 | |
| QSPNLTPPPTHTPHS | 1416 | A1L4H1 | |
| ISSHATSHPVAPPPP | 696 | Q6ZNA4 | |
| TSHPVAPPPPTHLAS | 701 | Q6ZNA4 | |
| HPPHTPSHPPSTRIT | 166 | Q9BQ15 | |
| PTHPTTSPTHPTTSP | 661 | Q6ZS17 | |
| PRTPHPSPAHSSRKP | 726 | Q6ZS17 | |
| THSPEVSHPHPPSPV | 686 | Q5VUA4 | |
| SPSPLPRTPTSTPVH | 471 | Q9ULM3 | |
| THPASTHTTPSPPST | 2696 | Q9UKN1 |